<DOC>
	<DOC>NCT00488007</DOC>
	<brief_summary>This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer disease. The benefit of this intervention will be studied in the cognitive, behavioural, quality of life and economic fields. 2groups are involved in this trial: Intervention group: 12 months' treatment with active hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment</brief_summary>
	<brief_title>Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Presbycusis</mesh_term>
	<criteria>&gt; 65 yearold Medical diagnosis of Alzheimer disease 15 ≤ MMSE ≤ 25 No hearing aids in the last 2 years Motivated caregiver living with the patient Sensorineural hearing loss Beginning of an anticholinesterasic treatment in the last 6 months Change in the anticholinesterasic treatment in the last 2 months</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Alzheimer disease</keyword>
	<keyword>Cognitive impairment</keyword>
	<keyword>Sensorineural hearing loss</keyword>
	<keyword>Hearing aids</keyword>
</DOC>